186 related articles for article (PubMed ID: 25111863)
1. PSGR promotes prostatic intraepithelial neoplasia and prostate cancer xenograft growth through NF-κB.
Rodriguez M; Luo W; Weng J; Zeng L; Yi Z; Siwko S; Liu M
Oncogenesis; 2014 Aug; 3(8):e114. PubMed ID: 25111863
[TBL] [Abstract][Full Text] [Related]
2. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
Cao W; Li F; Yao J; Yu J
BMC Cancer; 2015 Nov; 15():915. PubMed ID: 26582057
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers.
Weng J; Wang J; Cai Y; Stafford LJ; Mitchell D; Ittmann M; Liu M
Int J Cancer; 2005 Feb; 113(5):811-8. PubMed ID: 15499628
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression.
Rodriguez M; Siwko S; Zeng L; Li J; Yi Z; Liu M
Oncogene; 2016 Mar; 35(9):1153-62. PubMed ID: 26028029
[TBL] [Abstract][Full Text] [Related]
5. Exosomal prostate-specific G-protein-coupled receptor induces osteoblast activity to promote the osteoblastic metastasis of prostate cancer.
Li Y; Li Q; Gu J; Qian D; Qin X; Li D
Transl Cancer Res; 2020 Oct; 9(10):5857-5867. PubMed ID: 35117199
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
Weng J; Ma W; Mitchell D; Zhang J; Liu M
J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
[TBL] [Abstract][Full Text] [Related]
7. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
Li Y; Li Q; Li D; Gu J; Qian D; Qin X; Chen Y
Life Sci; 2021 Jan; 264():118638. PubMed ID: 33164833
[TBL] [Abstract][Full Text] [Related]
8. Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells.
Wang C; Ke Y; Liu S; Pan S; Liu Z; Zhang H; Fan Z; Zhou C; Liu J; Wang F
J Biol Chem; 2018 Sep; 293(38):14839-14849. PubMed ID: 30093411
[TBL] [Abstract][Full Text] [Related]
9. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer.
Xu LL; Stackhouse BG; Florence K; Zhang W; Shanmugam N; Sesterhenn IA; Zou Z; Srikantan V; Augustus M; Roschke V; Carter K; McLeod DG; Moul JW; Soppett D; Srivastava S
Cancer Res; 2000 Dec; 60(23):6568-72. PubMed ID: 11118034
[TBL] [Abstract][Full Text] [Related]
10. Activation of PSGR with β-ionone suppresses prostate cancer progression by blocking androgen receptor nuclear translocation.
Xie H; Liu T; Chen J; Yang Z; Xu S; Fan Y; Zeng J; Chen Y; Ma Z; Gao Y; He D; Li L
Cancer Lett; 2019 Jul; 453():193-205. PubMed ID: 30928381
[TBL] [Abstract][Full Text] [Related]
11. Quantitative expression profile of PSGR in prostate cancer.
Xu LL; Sun C; Petrovics G; Makarem M; Furusato B; Zhang W; Sesterhenn IA; McLeod DG; Sun L; Moul JW; Srivastava S
Prostate Cancer Prostatic Dis; 2006; 9(1):56-61. PubMed ID: 16231015
[TBL] [Abstract][Full Text] [Related]
12. Prostate-Specific G-Protein Coupled Receptor, an Emerging Biomarker Regulating Inflammation and Prostate Cancer Invasion.
Rodriguez M; Siwko S; Liu M
Curr Mol Med; 2016; 16(6):526-32. PubMed ID: 27280498
[TBL] [Abstract][Full Text] [Related]
13. Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy.
Matsueda S; Wang M; Weng J; Li Y; Yin B; Zou J; Li Q; Zhao W; Peng W; Legras X; Loo C; Wang RF; Wang HY
PLoS One; 2012; 7(9):e45756. PubMed ID: 23029225
[TBL] [Abstract][Full Text] [Related]
14. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine.
Rigau M; Morote J; Mir MC; Ballesteros C; Ortega I; Sanchez A; Colás E; Garcia M; Ruiz A; Abal M; Planas J; Reventós J; Doll A
Prostate; 2010 Dec; 70(16):1760-7. PubMed ID: 20672322
[TBL] [Abstract][Full Text] [Related]
15. Dual specificity phosphatase 1 expression inversely correlates with NF-κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism.
Gil-Araujo B; Toledo Lobo MV; Gutiérrez-Salmerón M; Gutiérrez-Pitalúa J; Ropero S; Angulo JC; Chiloeches A; Lasa M
Mol Oncol; 2014 Feb; 8(1):27-38. PubMed ID: 24080497
[TBL] [Abstract][Full Text] [Related]
16. Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-κB transactivation in LNCaP cells.
Dasari C; Yaghnam DP; Walther R; Ummanni R
Tumour Biol; 2017 May; 39(5):1010428317698382. PubMed ID: 28466782
[TBL] [Abstract][Full Text] [Related]
17. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
18. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M
Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.
Shukla S; Maclennan GT; Marengo SR; Resnick MI; Gupta S
Prostate; 2005 Aug; 64(3):224-39. PubMed ID: 15712212
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
Miyake H; Nelson C; Rennie PS; Gleave ME
Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
